This is where the course changes gear. An acute complaint ends with a disposition; chronic disease management ends with a system, and hypertension is the cleanest place to learn one. The work asks you to confirm a pressure before treating it, stage it against the guideline you intend to cite, estimate cardiovascular risk and record the figure, choose a first agent that respects the patient's other conditions, and build a monitoring schedule that says what happens when the target is missed.
We move into chronic disease at this point because it is the sensible place for it inside a primary care sequence we designed ourselves, not because any order of topics has been posted; syllabi here are not public and course guides require a student account. Your own shell decides whether this material is discussed, submitted as a written case, or handled in both forms. NRNP 6531 and NRNP6531 both lead to this page.
How a hypertension case is scored
Numbers on the page carry the first rows. Readings with the arm, the position and the cuff conditions attached, a stage named against a cited threshold, and a risk estimate reported as a percentage. Chronic-disease rubrics are built to be checked against figures, and prose without them scores as narrative.
Guideline traceability is the second axis. Every threshold, target and drug class you name should be attributable to a document the grader could open, cited to the version in force rather than to the edition you happened to be taught.
The individualization row is where two otherwise identical papers separate. Both students may select the same first agent; the one explaining why it suits this patient's kidney function, comorbidities and cost constraints takes the row.
The hypertension method, step by step
Six moves that turn a blood pressure reading into a defensible management plan.
-
Confirm the pressure before treating the number
Two or more readings on separate occasions with the right cuff size, the arm supported at heart level, feet flat and nobody talking, plus home or ambulatory readings where the case supplies them. Say how the diagnosis was confirmed, not only what it was.
-
Stage against the guideline you intend to cite
Name the source, name the threshold, place this patient inside it. A stage that appears without an attributable threshold is an opinion, and the plan built on top of it inherits the weakness.
-
Estimate the risk and write the figure down
Ten-year cardiovascular risk, the tool used and the inputs it took. That number moves lipid decisions and treatment intensity, and there is usually a row waiting for it.
-
Screen for secondary causes and organ damage
Renal function, electrolytes, urine albumin, lipids, glucose, an electrocardiogram, and the history features that hint at a secondary cause. Record what was ordered and what each order was chasing.
-
Choose the first agent from the comorbidities
Diabetes with albuminuria, heart failure, prior stroke, potential pregnancy, gout and chronic kidney disease all push the selection. Name the class, the drug, the starting dose and the reason the alternatives lost.
-
Schedule the follow-up and the escalation rule
When the pressure is rechecked, which laboratory tests repeat and at what interval, and what you will do at that visit if the target has not been reached.
A structure for a chronic hypertension write-up
How the sections usually divide in a management paper. The proportions are our planning suggestion and nothing more.
| Section | What belongs in it | What the row rewards |
|---|---|---|
| Subjective | Duration of hypertension, previous agents and why they stopped, adherence, symptoms of organ damage, lifestyle, family history, and everything taken including supplements and decongestants. | A history that already explains the current pressure and identifies what could be reversed without a prescription. |
| Objective | Serial readings with the technique described, weight, body mass index, waist measurement, cardiovascular findings and fundoscopy where available. | Measurements presented as data with their conditions, since the diagnosis itself rests on technique. |
| Diagnostics | Basic metabolic panel, urine albumin to creatinine ratio, lipid panel, glycated hemoglobin, thyroid function, electrocardiogram. | Each investigation attached to either a secondary cause or an end-organ question. |
| Assessment | The stage, the risk estimate, comorbid conditions and any organ damage identified. | A staged diagnosis with a cited threshold and a risk figure that later decisions genuinely use. |
| Plan, non-pharmacologic | Sodium reduction, dietary pattern, physical activity, weight, alcohol, tobacco and home monitoring instructions. | Advice that is quantified rather than a list of virtues, with a home routine the patient can actually follow. |
| Plan, pharmacologic and follow-up | Agent, dose, titration plan, monitoring bloods, review interval and the escalation trigger. | A regimen tied to the comorbidities, with the next decision point already written down. |
Annotated sample excerpt
Here is a follow-up section from our desk, built so a grader can score it line by line. Carry the structure across to your own patient.
The patient returns in four weeks with a home reading log kept twice daily for the seven days beforehand, morning and evening, two readings a minute apart on each occasion.1 A basic metabolic panel is scheduled between two and four weeks after starting the angiotensin converting enzyme inhibitor to check potassium and creatinine, with a creatinine rise beyond thirty percent prompting a call rather than a wait.2 Should the home average still exceed target at that visit, the agreed step is adding a thiazide-type diuretic rather than pushing the current agent to its ceiling, and the patient's agreement to that plan is recorded today.3
- 1The monitoring instruction is precise enough to follow without a second conversation, which is what turns a follow-up row from a date into a plan.
- 2Laboratory monitoring is timed to the drug and carries the threshold that would change behavior, so the safety row and the pharmacology row are answered in one place.
- 3Tomorrow's decision is made today and shared with the patient. Writing the next step into the current note is the clearest single marker of chronic-disease thinking.
Send us the hypertension case you were assigned and the free draft comes back staged, risk-scored and monitored at exactly this level of detail.
Five mistakes that cost points on a hypertension paper
- Treatment launched from a single reading. One elevated measurement is a finding, not a diagnosis, and a paper that skips confirmation loses the row before the plan begins.
- A stage named with no source attached. Thresholds differ between documents, so a stage without its citation cannot be checked and will not be credited.
- Risk described but never calculated. Saying the patient is at elevated risk without a tool, inputs and a percentage leaves a scored row half answered.
- Lifestyle counseling written as a list of virtues. Eat better and exercise more is not a plan; grams of sodium, minutes per week and a target weight change are.
- No escalation rule for a missed target. The reviewer wants to know what happens at the next visit if nothing improved, and one sentence settles it.
Pre-submission checklist
- The diagnosis rests on repeated readings with technique described
- The stage is cited to a named threshold
- A ten-year risk figure appears with the tool that produced it
- Secondary causes and organ damage have both been screened
- Agent selection is justified by this patient's comorbidities
- Monitoring intervals and an escalation trigger are written down
Chronic management paper due?
Send the case with the rubric attached, and a premium original draft comes back guideline-anchored and monitored to the last interval, inside the usual 24 to 48 hours. Our boundary is fixed: we produce the academic deliverable, the written case, the management paper, the discussion post. No part of what we do reaches a live patient encounter or a clinical evaluation.